Dietary lipids in early development: Relevance to obesity, immune and inflammatory disorders

Current Opinion in Endocrinology, Diabetes and Obesity

Volumn 14, Issue 5, 2007, Pages 359-364

  Innis, Sheila M ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Children; Dietary fatty acids; Inflammation; Obesity; Polyunsaturated fatty acids

Indexed keywords

FATTY ACID; LINOLEIC ACID; LIPID; OMEGA 3 FATTY ACID; OMEGA 6 FATTY ACID; SATURATED FATTY ACID; TRANS FATTY ACID; TRIACYLGLYCEROL;

ADIPOSE TISSUE; DISEASE COURSE; FAT INTAKE; HUMAN; IMMUNOPATHOLOGY; INFLAMMATION; LIPID COMPOSITION; LIPID METABOLISM; LIPID STORAGE; MEDIATOR; OBESITY; OXIDATIVE STRESS; PEDIATRICS; PROTEIN SYNTHESIS; REVIEW; SIGNAL TRANSDUCTION;

ADIPOSE TISSUE; CHILD; CHILD DEVELOPMENT; DIETARY FATS; ENERGY INTAKE; FATTY ACIDS; FATTY ACIDS, MONOUNSATURATED; HOMEOSTASIS; HUMANS; IMMUNE SYSTEM DISEASES; INFANT; INFLAMMATION; INFLAMMATION MEDIATORS; OBESITY; OXIDATIVE STRESS; TRANS FATTY ACIDS; TRIGLYCERIDES;

EID: 34548426900     PISSN: 1752296X     EISSN: None     Source Type: Journal    
DOI: 10.1097/MED.0b013e3282be90b9     Document Type: Review

References (61)

1. Burke V. Obesity in childhood and cardiovascular risk. Clin Exp Pharmacol Physiol 2006; 33:831-837. A recent review of trends and predictors of obesity and the metabolic syndrome in children.
2. Cruz ML, Shaibi GQ, Weigensberg MJ, et al. Pediatric obesity and insulin resistance: chronic disease risk and implications for treatment beyond body weight. Annu Rev Nutr 2005; 25:435-468.
3. Kaufan FR. Obesity and type 2 diabetes in children and youth. Curr Opin Endocrinol Diabetes 2006; 13:332-337. A recent review of the literature on type 2 diabetes in children, risk factors, diagnosis and management.
4. de Onis M, Garza C, Onyango AW, Borghiz E. Comparison of the WHO Child Growth Standards and the CDC 2000 Growth Charts. J Nutr 2007; 137:144-148. A comparison of child growth using the Centers for Disease Control and Prevention and recent WHO growth charts highlights the growth curve standard in determining changing rates of growth in infancy.
5. Schwarzenberg SJ, Sinaiko AR. Obesity and inflammation in children. Paediatr Resp Rev 2006; 7:239-246. A comprehensive recent review on obesity-related inflammation in children.
6. Frayn KN, Fielding BA, Karpe F. Adipose tissue fatty acid metabolism and cardiovascular disease. Curr Opin Lipidol 2005; 16:409-415.
7. Kershaw EE, Flier JS. Adipose tissue as an endocrine organ. J Clin Endocrinol Metab 2004; 89:2548-2556.
8. Singhal A. Nutritional interventions in infancy and childhood for prevention of atherosclerosis and the metabolic syndrome. In: Lucas A, Sampson HA (Eds.), Primary prevention in by nutrition intervention in infancy and childhood. Nestle Nutr Workshop Ser Pediatr Program 2006; 57:15-30. A recent review of the childhood origins of atherosclerosis, metabolic syndrome in childhood, and the concept of the early origins of adult disease.
9. Sbarbati A, Osculati F, Silvagni D, et al. Obesity and inflammation: evidence for an elementary lesion. Pediatrics 2006; 117:220-223. This recent paper provides histological evidence of early adipocyte degeneration, macrophage accumulation and inflammation in the adipose tissue of obese children.
10. Atabek ME, Pirgon O, Kivrak AS. Evidence for association between insulin resistance and premature carotid atherosclereosis in childhood obesity. Pediatr Res 2007; 61:345-349. This recent study shows the inverse assocaiton between carotid intima media thickness and measures of insulin sensitivity, but not traditional lipid risk factors or homocysteine in 50 obese children.
11. Canete R, Gil-Campos M, Aguilera CM, Gil A. Development of insulin-resistance and its relation to diet in the obese child. Eur J Nutr 2007; In press.
12. Kapiotis S, Holzer G, Schaller G, et al. A pro-inflammatory state is detectable in obese children and is accompanied by functional and morphological vascular changes. Arterioscler Thromb Vasc Biol 2006; 26:2541-2546.
13. Sharma AM, Staels B. Review: peroxisome proliferator-activated receptor γ and adipose tissue-understanding obesity-related changes in regulation of lipid and glucose metabolism. J Endocrinol Metab 2007; 92:386-395. A comprehensive, authoritative review on PPARγ in adipose tissue and the potential beneficial role of PPARγ activiation in regulating the secretion of adipokines and NEFAs from adipocytes and inflammatory mediators from macrophages.
14. Trayhurn P. Adipocyte biology. Obesity Rev 2007; 8:41-44.
15. Fain JN. Release of interleukins and other inflammatory cytokines by human adipose tissue is enhanced in obesity primarily due to nonfat cells. Vitamin Horm 2006; 74:44-47.
16. Lopez-Soriano J, Chiellini C, Maffei M, et al. Roles of skeletal muscle and peroxisome proliferator-activated receptors in the development and treatment of obesity. Endocrine Rev 2006; 27:318-329. A recent review of PPARs focusing particularly on the role of skeletal muscle in lipid metabolism.
17. Yim JE, Heshka S, Albu J, et al. Intermuscular adipose tissue rivals visceral adipose tissue in independent associations with cardiovascular risk. Int J Obes (Lond) 24 April 2007; E-pub ahead of print. doi:10.1038/sj.ijo.0803621. This recent study showed that intramuscular adipose tissue is independently inversely related to fasting glucose, after controlling for adipose tissue in other sites.
18. Wu CH, Heshka S, Wang J, et al. Truncal fat in relation to total body fat: influences of age, sex, ethnicity and fatness. Int J Obes (Lond) 24 April 2007; E-pub ahead of print. doi:10.1038/sj.ijo.0803624. A recent study demonstrating the effect of ethnicity on truncal fat accumulation.
19. Innis SM. Perinatal biochemistry and physiology of long chain polyunsaturated fatty acids. J Pediatr 2003; 143 (Suppl 4):S1-S8.
20. Innis SM. Human milk: maternal dietary lipids and infant development. Proc Br Nutr Soc 2007; 66:397-404. A recent review of the effects of maternal dietary fatty acids on essential fatty acid transfer to the infant before and after birth.
21. Burdge GC. Metabolism of alpha-linolenic acid in humans. Prostagland Leukotr Essent Fatty Acids 2006; 75:161-168.
22. Goyens PL, Spiker ME, Zock PL, et al. Compartmental modeling to quantify alphalinolenic acid and conversion after longer term intake of multiple tracer boluses. J Lipid Res 2005; 46:1474-1483.
23. Hussein N, Ah-Sing E, Wilkinson P, et al. Long-chain conversion of [IBC] linoleic acid and alpha linolenic acid in response to marked changes in other dietary intake in men. J Lipid Res 2005; 64:42-50.
24. Liou A, King DJ, Zibrik D, Innis SM. Decreasing linoleic acid with constant alpha linoleic acid in dietary fats increases (n-3) polyunsaturated fatty acids in plasma phospholipids in healthy men. J Nutr 2007; 137:1-8. This randomized dietary intervention showed that decreasing linolenic acid intakes do not influence circulating arachidonic acid, but increases EPA.
25. Calder PC. N-3 Polyunsaturated fatty acids, inflammation, and inflammatory disease. Am J Clin Nutr 2006; 83:1505S-1519S.
26. Innis SM. Trans fatty intakes during pregnancy, infancy and early childhood. Atheroscler Suppl 2006; 7:17-20.
27. Innis SM. Essential fatty acid transfer and fetal development. Placenta 2005; 26 (Suppl A):S70-S75.
28. Elias SL, Innis SM. Newborn infant plasma transconjugated linoleic, n-6 and n-3 fatty acids are related to maternal plasma fatty acids, length of gestation and birth weight and length. Am J Clin Nutr 2001; 73:804-814.
29. Yuhas R, Pramuk K, Lien EL. Human milk fatty acid composition from nine countries varies most in DHA. Lipids 2006; 41:851-858.
30. Friesen RW, Innis SM. Trans fatty acids in human milk in Canada: a decline with the introduction of trans fat food labelling. J Nutr 2006; 136:1-4.
31. Innis SM, Vaghri Z, King DJ. N-6 docosapentaenoic acid is not a predictor of low docosahexaenoic acid status in Canadian preschool children. Am J Clin Nutr 2004; 80:768-773.
32. Khanapure SP, Garvey DS, Janero DR, Letts LE. Eicosanoids in inflammation: biosynthesis, pharmacology and therapeutic frontiers. Curr Opin Med Chem 2007; 7:311-340.
33. Fritsche K. Fatty acids as modulators of the immune response. Annu Rev Nutr 2006; 26:45-73.
34. Medhora M, Dhanasekaran A, Gruenloh SK, et al. Emerging mechanisms for growth and protection of the vasculature by cytochrome P450-derived products of arachidonic acid and other eicosanoids. Prostagland Other Lipid Mediat 2007; 82:19-29.
35. Serhan CN, Savill J. Resolution of inflammation: the beginning programs the end. Nat Immunol 2005; 6:1191-1197.
36. Ailhand G, Massiera F, Weill P, et al. Temporal changes in dietary fats: role of n-6 polyunsaturated fatty acids in excessive adipose tissue development and relationship to obesity. Prog Lipid Res 2006; 45:203-236.
37. Deckelbaum RJ, Worgall TS, Seo T. N-3 fatty acids and gene expression. Am J Clin Nutr 2006; 83:1520S-1525S.
38. Feige JN, Gelman L, Michalik L, et al. From molecular action to physiological outputs: peroxisome proliferator-activator receptors are nuclear receptors at the cross reoads of cellular functions. Prog Lipid Res 2006; 45:120-159.
39. Lombardo YB, Chicco AG. Effect of dietary polyunsaturated n-3 fatty acids on dyslipidemia and insulin resistance in rodents and humans. A review. J Nutr Biochem 2006; 17:1-13. A recent review of studies on the effects of n-3 fatty acids from fish oil on high fat and sucrose-induced change in adipose and skeletal muscle, focusing on dyslipidemia, glucose homeostasis and insulin resistance.
40. McAuley KA, Mann JI. Nutritional determinants of insulin resistance. J Lipid Res 2006; 47:1668-1676.
41. Chapkin RS, Davidson LA, Ly L, et al. Immunomodulatory effects of (n-3) fatty acids: putative link to inflammation and colon cancer. J Nutr 2007; 137:200S-204S.
42. Armoni M, Bar-Yoseph F, Milo S, Karmelli E. Free fattyacids repress GLUT4 gene expression in cardiac muscle via novel response elements. J Biol Chem 2005; 280:34786-34795.
43. Jové M, Planavila A, Sanchez RM, et al. Palmitate induces tumor necrosis factor-α expression in c2c12 skeletal muscle cells by a mechanism involving protein kinase c and nuclear factor-κb activation. Endocrinology 2006; 147:552-561.
44. Lee JY, Sohn KH, Rhee SH, Hwang D. Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxgenase-2 mediated through Toll-like receptor 4. J Biol Chem 2001; 276:16683-16689.
45. Suganami T, Tanimoto-Koyama K, Nishida J, et al. Role of the Toll-like receptor 4, NF-kappa β pathway in saturated fatty acid-induced infallmaory changes in the interaction between adipocytes and macrophages. Arterioscler Thromb Vasc Biol 2007; 27:84-91. These studes implicate saturated fatty acids released from adipocytes as ligands for Toll-like receptor 4, leading to the activation of NF-κB and inflammatory changes in adipocytes and macrophages.
46. Kuhnt K, Wagner A, Kraft J, et al. Dietary supplementation with 11trans- and 12trans-18:1 and oxidative stress in humans. Am J Clin Nutr 2006; 84:981-988. A randomized intervention with 6 g/day trans fatty acids in a 30% energy from fat diet for 6 weeks increased urinary urinary markers of oxidative stress, but had no effect on circulating inflammaory mediators in normal weight adults.
47. Ghosh S, Kewalramani G, Yuen G, et al. Induction of mitochondrial nitrative damage and cardiac dysfunction by chronic provision of dietary omega-6 polyunsaturated fatty acids. Free Radic Biol Med 2006; 41:1413-1424.
48. Viswanathan S, Mammock BD, Newman JW, et al. Involvement of C4P 2C9 in mediating the proinflammatory effects of linoleic acid in vascular endothelial cells. J Am Coll Nutr 2003; 22:502-510.
49. Lopez-Garcia E, Schulze MB, Meigs JB, et al. Consumption of trans fatty acids is related to plasma biomarkers of inflammation and endothelial dysfunction. J Nutr 2005; 138:562-566.
50. Denburg JA, Hatfield HM, Cyr MM, et al. Fish oil supplementation modifies neonatal progenitors at birth in infants at risk of atopy. Pediatr Res 2005; 67:276-281.
51. Dunstan JA, Mori TA, Borden A, et al. Maternal fish oil supplementation in pregnancy reduces interleukin-13 levels in cord blood of infants at high risk of atopy. Clin Exp Allergy 2003; 33:442-448.
52. Gold DR, Willwerth BM, Tantisira KG, et al. Assocations of cord blood fatty acids with lymphocyte proliferation, IL-13 and IFN-γ. J Allergy Clin Immunol 2006; 117:931-938.
53. Klein-Platat C, Drai J, Oujaa M, et al. Plasma fatty acid composition is associated with the metabolic syndrome and low-grade inflammation in overweight adolescents. Am J Clin Nutr 2005; 82:1178-1184.
54. Karlsson M, Mårild S, Brandberg J, et al. Serum phospholipid fatty acids, adipose tissue, and metabolic markers in obese adolescents. Obesity 2006; 14:1931-1939.
55. Okada T, Furuhashi N, Kuromori Y, et al. Plasma palmitoleic acid content and obesity in children. Am J Clin Nutr 2005; 82:747-750.
56. Aldamiz-Echevarria L, Prieto JA, Andrade F, et al. Arachidonic acid content in adipose tissue is associated with insulin resistance in healthy children. J Pediatr Gastroenterol Nutr 2007; 44:77-83.
57. Chen AK, Roberts CK, Barnard RJ. Effect of a short-term diet and exercise intervention on metabolic syndrome in overweight children. Metabolism 2006; 55:871-878. A short-term dietary intervention in overweight children that showed a reversal of the metabolic syndrome with modest improvements in body fat.
58. Roberts CK, Chen AK, Barnard RJ. Effect of short-term diet and exercise intervention in youth on atherosclerotic risk factors. Atherosclerosis 2007; 191:98-106. This recent study reported decreases in several inflammatory cytokines after shortterm dietary modification with a low-fat diet in overweight children.
59. Kaitosaari T, Rohnemaa T, Vikari J, et al. Low-saturated fat dietary counseling starting in infancy improves insulin sensitivity in 9-year-old healthy children. The Special Turku Coronary Risk Factor Intervention Project for Children (STRIP) Study. Diabetes Care 2006; 29:781-785. This important longitudinal study shows dietary counseling to maintain a low saturated fat intake from infancy has a positive effect on insulin sensitivity in later childhood.
60. Haugaard SB, Madsbad S, Hoy CE, Vaag A. Dietary intervention increases long chain n-3 long-chain polyunsaturated fatty acids in skeletal muscle phospholipids of obese subjects. Implications for insulin sensitivity. Clin Endocrinol 2006; 64:169-178. This 6-month hypocaloric low-fat intervention showed increased arachidonic and docosahexaenoic acid in muscle phospholipid and improved insulin sensitivity.
61. Mozaffarian D, Katan MG, Ascherio A, et al. Trans fatty acids and cardiovascular disease. N Engl J Med 2006; 354:1601-1613.